Africa’s vaccine cloning gamble

Africa’s vaccine cloning gamble
Jess Frampton

Less than a year after the world started putting COVID vaccines into people's arms, most regions have immunized at least half their populations, but Africa still lags behind. With industrialized nations hoarding jabs and the COVAX facility faltering, barely five percent of the African population is fully vaccinated.

Some enterprising South African scientists are now making a bold bid to change that, with an experiment that could benefit not only Africa's 54 nations and billion people, but the entire world: Afrigen Biologics and Vaccines, a Cape Town-based startup, has developed a plan to reverse-engineer Moderna's mRNA shot and manufacture it for priority distribution on the continent.

How are they going to do it? The ingredients in Moderna's vaccine "recipe" are mostly publicly available — the trick is to figure out what to do with them. It's like having all the ingredients and measurements to bake a cake, but only vague instructions for each step.

Given that the Moderna vaccine was developed with US taxpayer money, lawyers are still figuring out which aspects of the process belong solely to the company. But that may be moot for now: the company says it won't sue, leaving Afrigen apparently in the clear to go ahead.

Cloning an mRNA vaccine would be a huge win for South Africa. It would be the equivalent of the moon landing in terms of accomplishment and prestige for a nation that too often grabs headlines for all the wrong reasons. Moreover, the project is backed and funded by the World Health Organization, so if the code is cracked, the formula would be made available to all as a public good across the whole continent and the wider developing world.

A highly effective yet affordable jab that can be manufactured anywhere could be a game-changer to stop more contagious COVID variants from emerging where the population is still unvaccinated. What's more, the sky's the limit when it comes to mRNA's potential to create vaccines against other diseases endemic to Africa such as Ebola, less infectious but way deadlier than COVID.

But don't get too excited just yet. The startup says it'll take up to a year to reverse-engineer Moderna's jab. Also, getting the formula right is only one piece of the puzzle. Afrigen would then need to figure out how to mass-produce, store, and deliver the vaccine around a continent with often poor infrastructure, not to mention getting raw materials at a moment when global supply chains are already stretched thin.

There's a political angle too. In the US, the Biden administration wants Moderna to sell more vaccines to COVAX at cost, and is facing growing criticism for treating the company with kid gloves after ignoring Biden's call to boost production for low-income countries despite Uncle Sam being Moderna's research sugar daddy.

Meanwhile, public health advocates are urging the National Institutes of Health to force Moderna to give up its secret sauce, and calling out the US government for paying lip service to waiving patents and global vaccine equity while not pushing the drugmakers harder to share their tech or prioritize supply for countries with low vaccination rates.

Technically, the Biden administration has some leverage because the White House bankrolled Moderna's vaccine research through the NIH and Operation Warp Speed. But twisting Moderna's arm would be a hard sell for the US government, traditionally reticent to meddle with Big Pharma and with little to gain (politically at home) from vaccinating other countries.

Moderna, for its part, says that right now it's better for the company to expand production itself than to share its tech because scaling up production in Africa will take too long. More broadly, it's also playing a longer game of aiming to dominate the post-COVID mRNA manufacturing landscape along with Pfizer.

No one knows if reverse-engineering mRNA COVID vaccines will work, but then again no one's tried before. Still, the upshot is that there's a huge opportunity despite uncertainty about the science, the business of producing the jab, and the politics behind it all.

More from GZERO Media

Paige Fusco

In a way, Donald Trump’s return means Putin has finally won. Not because of the silly notion that Trump is a “Russian agent” – but because it closes the door finally and fully on the era of post-Cold War triumphalist globalism that Putin encountered when he first came to power.

Venezuelan opposition leader Maria Corina Machado greets supporters at a protest ahead of the Friday inauguration of President Nicolas Maduro for his third term, in Caracas, Venezuela January 9, 2025.
REUTERS/Leonardo Fernandez Viloria

Regime forces violently detained Venezuelan opposition leader María Corina Machado as she left a rally in Caracas on Thursday, just one day before strongman President Nicolás Maduro begins his third term.

Paige Fusco

Justin Trudeau is leaving you, Donald Trump is coming for you. The timing couldn’t be worse. The threat couldn’t be bigger. The solutions couldn’t be more elusive, writes GZERO Publisher Evan Solomon.

- YouTube

Is international order on the precipice of collapse? 2025 is poised to be a turbulent year for the geopolitical landscape. From Canada and South Korea to Japan and Germany, the world faces a “deepening and rare absence of global leadership with more chaos than any time since the 1930s,” says Eurasia Group chairman Cliff Kupchan during a GZERO livestream to discuss the 2025 Top Risks report.

During the Munich Security Conference 2025, the BMW Foundation will again host the BMW Foundation Herbert Quandt Pavilion. From February 13th to 15th, we will organize panels, keynotes, and discussions focusing on achieving energy security and economic prosperity through innovation, policy, and global cooperation. The BMW Foundation emphasizes the importance of science-based approaches and believes that the energy transition can serve as a catalyst for economic opportunity, sustainability, and democratic resilience. Our aim is to facilitate solution-oriented dialogues between business, policy, science, and civil society to enhance Europe’s competitiveness in the energy and technology sectors, build a strong economy, and support a future-proof society. Read more about the BMW Foundation and our Pavilion at the Munich Security Conference here.

U.S. President Donald Trump and Israel's Prime Minister Benjamin Netanyahu shake hands after speaking to reporters before their meeting at the King David Hotel in Jerusalem on May 22, 2017.

REUTERS/Jonathan Ernst

President-elect Donald Trump raised eyebrows this week by sharing a video clip on his Truth Social account that shows economist Jeffrey Sachs trashing Israel’s Prime Minister Benjamin Netanyahu.